Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 149 citing Bauer: Risk for fracture in women with low serum levels of thyroid-stimulating hormone. (0.10 sec) 

Subclinical thyroid disease: scientific review and guidelines for diagnosis and management

- nih.gov
MI Surks, E Ortiz, GH Daniels, CT Sawin, … - Jama, 2004 - Am Med Assoc
Context Patients with serum thyroid-stimulating hormone (TSH) levels outside the
reference range and levels of free thyroxine (FT 4 ) and triiodothyronine (T 3 )
within the reference range are common in clinical practice. The necessity ...
Cited by 791 - Related articles - BL Direct - All 15 versions

[PDF] Thyroid carcinoma


SI Sherman - management - pittsurg.org
Thyroid carcinoma accounts for roughly 1% of all new malignant disease, about
0·5% of cancers in men and 1·5% in women.1 Of these, at least 94% are
differentiated thyroid carcinomas that derive from the follicular ...
Cited by 329 - Related articles - View as HTML - All 7 versions

Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the …

- annals.org
M Helfand - Annals of internal medicine, 2004 - Am Coll Physicians
Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Background: Subclinical thyroid dysfunction is a risk factor for developing ...
Cited by 99 - Related articles - All 9 versions

The molecular actions of thyroid hormone in bone

- cell.com
JH Duncan Bassett, GR Williams - Trends in Endocrinology & Metabolism, 2003 - Elsevier
Thyroid hormone (T 3 ) is essential for the normal development of endochondral
and intramembranous bone and plays an important role in the linear growth and
maintenance of bone mass. Childhood T 3 deficiency results in retardation ...
Cited by 84 - Related articles - All 6 versions

Subclinical hyperthyroidism: clinical features and treatment options

- eje-online.org
B Biondi, EA Palmieri, M Klain, M Schlumberger … - European Journal of Endocrinology, 2005 - EFES
Subclinical hyperthyroidism appears to be a common disorder. It may be caused by
exogenous or endogenous factors: excessive TSH suppressive therapy with
L-thyroxine (L-T4) for benign thyroid nodular disease, differentiated ...
Cited by 80 - Related articles - All 8 versions

The thyrotropin reference range should remain unchanged


MI Surks, G Goswami, GH Daniels - Journal of Clinical Endocrinology & Metabolism, 2005 - Endocrine Soc
Context: Recent recommendations to decrease the upper limit of the TSH reference
range from 4.5 to 2.5 mIU/liter, based on the high proportion of normal people
whose serum TSH is less than 2.5 mIU/liter and the observation that those ...
Cited by 73 - Related articles - BL Direct - All 5 versions

Risk factors for a first-incident radiographic vertebral fracture in women≥ 65 years of age: …

- escholarship.org
MC Nevitt, SR Cummings, KL Stone, L … - Journal of Bone and Mineral Research, 2004 - jbmronline.org
Vertebral fractures in older women signal an increased risk of additional
osteoporotic fractures. To identify risk factors for first vertebral fractures,
we studied 5822 women ≥65 years of age who had no fracture on baseline ...
Cited by 68 - Related articles - All 7 versions

The clinical significance of subclinical thyroid dysfunction

- endojournals.org
B Biondi, DS Cooper - Endocrine Reviews, 2008 - Endocrine Soc
Subclinical thyroid disease (SCTD) is defined as serum free T 4 and free T 3
levels within their respective reference ranges in the presence of abnormal
serum TSH levels. SCTD is being diagnosed more frequently in clinical ...
Cited by 64 - Related articles - BL Direct - All 7 versions

Thyroid hormone in health and disease

- endocrinology-journals.org
K Boelaert, JA Franklyn - Journal of Endocrinology, 2005 - Soc Endocrinology
Thyroid disease is common, affecting around 2% of women and 0.2% of men in the
UK. Our understanding of the effects of thyroid hormones under physiological
circumstances, as well as in pathological conditions, has increased ...
Cited by 62 - Related articles - BL Direct - All 3 versions

Thyroid-hormone therapy and thyroid cancer: a reassessment


B Biondi, S Filetti, M Schlumberger - Nature Reviews Endocrinology, 2005 - nature.com
Experimental studies and clinical data have demonstrated that thyroid-cell
proliferation is dependent on thyroid-stimulating hormone (TSH), thereby
providing the rationale for TSH suppression as a treatment for ...
Cited by 59 - Related articles - BL Direct - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google